168 related articles for article (PubMed ID: 34098051)
1. Cationic lipid nanoparticle production by microfluidization for siRNA delivery.
Liu X; Bahloul B; Lai Kuen R; Andrieux K; Roques C; Scherman D
Int J Pharm; 2021 Aug; 605():120772. PubMed ID: 34098051
[TBL] [Abstract][Full Text] [Related]
2. Effects of cationic lipids in cationic liposomes and disaccharides in the freeze-drying of siRNA lipoplexes on gene silencing in cells by reverse transfection.
Hattori Y; Hu S; Onishi H
J Liposome Res; 2020 Sep; 30(3):235-245. PubMed ID: 31185779
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
4. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
5. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation.
Barichello JM; Ishida T; Kiwada H
Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901
[TBL] [Abstract][Full Text] [Related]
6. Efficient Cellular Knockdown Mediated by siRNA Nanovectors of Gemini Cationic Lipids Having Delocalizable Headgroups and Oligo-Oxyethylene Spacers.
Martínez-Negro M; Kumar K; Barrán-Berdón AL; Datta S; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
ACS Appl Mater Interfaces; 2016 Aug; 8(34):22113-26. PubMed ID: 27508330
[TBL] [Abstract][Full Text] [Related]
7. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study.
Khatri N; Baradia D; Vhora I; Rathi M; Misra A
AAPS PharmSciTech; 2014 Dec; 15(6):1630-43. PubMed ID: 25145330
[TBL] [Abstract][Full Text] [Related]
9. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
[TBL] [Abstract][Full Text] [Related]
10. Spheroplexes: Hybrid PLGA-cationic lipid nanoparticles, for in vitro and oral delivery of siRNA.
Arruda DC; Lachagès AM; Demory H; Escriou G; Lai-Kuen R; Dugas PY; Hoffmann C; Bessoles S; Sarrabayrouse G; Malachias A; Finet S; Gastelois PL; de Almeida Macedo WA; da Silva Cunha A; Bigey P; Escriou V
J Control Release; 2022 Oct; 350():228-243. PubMed ID: 35995297
[TBL] [Abstract][Full Text] [Related]
11. Effect of the combination of cationic lipid and phospholipid on gene-knockdown using siRNA lipoplexes in breast tumor cells and mouse lungs.
Hattori Y; Tang M; Aoki A; Ezaki M; Sakai H; Ozaki KI
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594053
[TBL] [Abstract][Full Text] [Related]
12. Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery.
Malfanti A; Sami H; Balasso A; Marostica G; Arpac B; Mastrotto F; Mantovani G; Cola E; Anton M; Caliceti P; Ogris M; Salmaso S
J Control Release; 2023 Nov; 363():101-113. PubMed ID: 37722420
[TBL] [Abstract][Full Text] [Related]
13. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation.
Kubota K; Onishi K; Sawaki K; Li T; Mitsuoka K; Sato T; Takeoka S
Int J Nanomedicine; 2017; 12():5121-5133. PubMed ID: 28790820
[TBL] [Abstract][Full Text] [Related]
14. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
15. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
Kapoor M; Burgess DJ
Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
Sato Y; Matsui H; Sato R; Harashima H
J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
[TBL] [Abstract][Full Text] [Related]
17. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes.
Hattori Y; Saito H; Oku T; Ozaki KI
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169
[TBL] [Abstract][Full Text] [Related]
18. Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry.
Hirsch-Lerner D; Barenholz Y
Biochim Biophys Acta; 1999 Nov; 1461(1):47-57. PubMed ID: 10556487
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
[TBL] [Abstract][Full Text] [Related]
20. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]